Buprenorphin Actavis 35 micrograms/h transdermal patch
Land: Bulgarien
Sprache: Bulgarisch
Quelle: Изпълнителна агенция по лекарствата
Gebrauchsinformation
(PIL)
10-07-2023
Fachinformation
(SPC)
18-10-2021
Verfügbar ab:
Actavis Group PTC ehf.
ATC-Code:
N02A
Dosierung:
35 micrograms/h transdermal patch
Produktbesonderheiten:
Buprenorphin Actavis, 35 micrograms/h transdermal patch x2, x3, x4, x5, x8, x10, x12, x16, x18, x20, x24, x25, x30;
Berechtigungsdatum:
2015-08-06
